INSMED Inc — Director's Dealing 2022

Aug 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-08-10

Reporting Person: Wise John Drayton (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-10	Common Stock	S	258	$27.79	Disposed	78767	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.